Clinical Trial Update: A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

View source ↗

Summary

A completed clinical trial evaluated the characteristics of patients with advanced renal cell carcinoma treated with Nexavar (sorafenib).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Renal Cell, Carcinoma, Renal Cell (Advanced) | Status: COMPLETED